Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 5106469, 10 pages
https://doi.org/10.1155/2018/5106469
Research Article

Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers

1Medicinal Plants Research Group, Deanship of Scientific Research, King Abdulaziz University, Jeddah, Saudi Arabia
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
3Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
4Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
5Pharmacology Department, Medical Division, National Research Centre, Giza, Egypt
6Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
7Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Correspondence should be addressed to Ashraf B. Abdel-Naim; moc.oohay@mianba

Received 12 October 2017; Revised 25 November 2017; Accepted 17 December 2017; Published 13 February 2018

Academic Editor: Lotfi Aleya

Copyright © 2018 Ashraf B. Abdel-Naim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Martin and P. H. S. Correa, “Bone quality and osteoporosis therapy,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 54, no. 2, pp. 186–199, 2010. View at Publisher · View at Google Scholar
  2. K. Akesson, “New approaches to pharmacological treatment of osteoporosis,” Bulletin of the World Health Organization, vol. 81, no. 9, pp. 657–664, 2003. View at Google Scholar
  3. K. E. Ensrud and C. J. Crandall, “Osteoporosis,” Annals of Internal Medicine, vol. 167, no. 3, pp. ITC17–ITC32, 2017. View at Publisher · View at Google Scholar
  4. T. P. van Staa, E. M. Dennison, H. G. Leufkens, and C. Cooper, “Epidemiology of fractures in England and Wales,” Bone, vol. 29, no. 6, pp. 517–522, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. D. Leslie, C. J. Metge, M. Azimaee et al., “Direct costs of fractures in Canada and trends 1996–2006: a population-based cost-of-illness analysis,” Journal of Bone and Mineral Research, vol. 26, no. 10, pp. 2419–2429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. van den Bergh, T. A. van Geel, and P. P. Geusens, “Osteoporosis, frailty and fracture: implications for case finding and therapy,” Nature Reviews Rheumatology, vol. 8, no. 3, pp. 163–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Hardcastle, L. Aucott, W. D. Fraser, D. M. Reid, and H. M. Macdonald, “Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women,” European Journal of Clinical Nutrition, vol. 65, no. 3, pp. 378–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. Brass, “Estrogens and stroke: use of oral contraceptives and postmenopausal use of estrogen: current recommendations,” Current Treatment Options in Neurology, vol. 6, no. 6, pp. 459–467, 2004. View at Publisher · View at Google Scholar
  9. W. Strampel, R. Emkey, and R. Civitelli, “Safety considerations with bisphosphonates for the treatment of osteoporosis,” Drug Safety, vol. 30, no. 9, pp. 755–763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Yardley, “Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer,” Breast Cancer: Targets and Therapy, vol. 8, pp. 73–82, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Wu, Z. Ling, X. Feng, C. Mao, and Z. Xu, “Herb medicines against osteoporosis: active compounds & relevant biological mechanisms,” Current Topics in Medicinal Chemistry, vol. 17, no. 15, pp. 1670–1691, 2017. View at Publisher · View at Google Scholar
  12. A. C. Hardcastle, L. Aucott, D. M. Reid, and H. M. Macdonald, “Associations between dietary flavonoid intakes and bone health in a Scottish population,” Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 941–947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Welch, A. MacGregor, A. Jennings, S. Fairweather-Tait, T. Spector, and A. Cassidy, “Habitual flavonoid intakes are positively associated with bone mineral density in women,” Journal of Bone and Mineral Research, vol. 27, no. 9, pp. 1872–1878, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Welch and A. C. Hardcastle, “The effects of flavonoids on bone,” Current Osteoporosis Reports, vol. 12, no. 2, pp. 205–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Gibbs, Chemotaxonomy of Flowering Plants, McGill-Queen’s University Press, Montreal, 1974. View at Publisher · View at Google Scholar
  16. F. Oke-Altuntas, S. Ipekcioglu, A. Sahin Yaglioglu, L. Behcet, and I. Demirtas, “Phytochemical analysis, antiproliferative and antioxidant activities of Chrozophora tinctoria: a natural dye plant,” Pharmaceutical Biology, vol. 55, no. 1, pp. 966–973, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Maurya, M. Semwal, and S. K. Dubey, “Pharmacological evaluation of Chrozophora tinctoria as wound healing potential in diabetic rat’s model,” BioMed Research International, vol. 2016, Article ID 7475124, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. H. M. Abdallah, F. M. Almowallad, A. Esmat, I. A. Shehata, and E. A. Abdel-Sattar, “Anti-inflammatory activity of flavonoids from Chrozophora tinctoria,” Phytochemistry Letters, vol. 13, pp. 74–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Hecker, “Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae,” Cancer Research, vol. 28, no. 11, pp. 2338–2349, 1968. View at Google Scholar
  20. U. W. Hawas, “Antioxidant activity of brocchlin carboxylic acid and its methyl ester from Chrozophora brocchiana,” Natural Product Research, vol. 21, no. 7, pp. 632–640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” JNCI Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. H. A. Mosli, M. F. Tolba, A. M. Al-Abd, and A. B. Abdel-Naim, “Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells,” Toxicology Letters, vol. 220, no. 3, pp. 247–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, article RESEARCH0034, 2002. View at Google Scholar
  24. W. Gerhardt, M. L. Nielsen, O. V. Nielsen, J. S. Olsen, and B. E. Statland, “Clinical evaluation of routine measurement of liver and bone alkaline phosphatases in human serum: differential inhibition by L-phenylalanine and carbamide (urea) on the LKB 8600 reaction rate analyzer,” Clinica Chimica Acta, vol. 53, no. 3, pp. 291–297, 1974. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Y. Fu and D. Muller, “Simple, rapid enzyme-linked immunosorbent assay (ELISA) for the determination of rat osteocalcin,” Calcified Tissue International, vol. 64, no. 3, pp. 229–233, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. P. D. Papapetrou, “Bisphosphonate-associated adverse events,” Hormones, vol. 8, no. 2, pp. 96–110. View at Publisher · View at Google Scholar
  27. A. B. Abdel-Naim, A. A. Alghamdi, M. M. Algandaby et al., “Phenolics isolated from Aframomum meleguta enhance proliferation and ossification markers in bone cells,” Molecules, vol. 22, no. 9, 2017. View at Publisher · View at Google Scholar
  28. I. Fernandes, R. Pérez-Gregorio, S. Soares, N. Mateus, and V. de Freitas, “Wine flavonoids in health and disease prevention,” Molecules, vol. 22, no. 4, p. 292, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-L. Shen and M.-C. Chyu, “Tea flavonoids for bone health: from animals to humans,” Journal of Investigative Medicine, vol. 64, no. 7, pp. 1151–1157, 2016. View at Publisher · View at Google Scholar
  30. Y. Gao, F. Yang, H. Xi, W. Li, P. Zhen, and K. Chen, “Effects of icariin total flavonoids capsule on bone mineral density and bone histomorphometry in growing rats,” Zhejiang Da Xue Xue Bao. Yi Xue Ban, vol. 45, no. 6, pp. 581–586, 2016. View at Google Scholar
  31. Y.-L. Huang, C.-C. Shen, Y.-C. Shen, W.-F. Chiou, and C.-C. Chen, “Anti-inflammatory and Antiosteoporosis flavonoids from the rhizomes of Helminthostachys zeylanica,” Journal of Natural Products, vol. 80, no. 2, pp. 246–253, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Carbonezi, L. Hamerski, A. A. L. Gunatilaka et al., “Bioactive flavone dimers from Ouratea multiflora (Ochnaceae),” Revista Brasileira de Farmacognosia, vol. 17, no. 3, pp. 319–324, 2007. View at Publisher · View at Google Scholar
  33. Y.-M. Zhang, R. Zhan, Y.-G. Chen, and Z.-X. Huang, “Two new flavones from the twigs and leaves of Cephalotaxus lanceolata,” Phytochemistry Letters, vol. 9, pp. 82–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Shabana, M. El-Sherei, M. Moussa, A. Sleem, and H. Abdallah, “Investigation of phenolic constituents of Carduncellus eriocephalus Boiss. Var. albiflora Gauba and their biological activities,” Natural Product Communications, vol. 2, pp. 823–828, 2007. View at Google Scholar
  35. M. Plioukas, A. Termentzi, C. Gabrieli, M. Zervou, P. Kefalas, and E. Kokkalou, “Novel acylflavones from Sideritis syriaca ssp. syriaca,” Food Chemistry, vol. 123, no. 4, pp. 1136–1141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Lecomte, M. Lelong, G. Bourgine, T. Efstathiou, C. Saligaut, and F. Pakdel, “Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation,” Toxicology and Applied Pharmacology, vol. 325, pp. 61–70, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Wang, N. Zheng, J. Dong, X. Wang, L. Liu, and J. Huang, “Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 171, pp. 318–327, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Hyun, H. Park, J. Jeong et al., “Effects of watercress containing rutin and rutin alone on the proliferation and osteogenic differentiation of human osteoblast-like MG-63 cells,” The Korean Journal of Physiology & Pharmacology, vol. 18, no. 4, pp. 347–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Soto and C. Sonnenschein, “The role of estrogens on the proliferation of human breast tumor cells (MCF-7),” Journal of Steroid Biochemistry, vol. 23, no. 1, pp. 87–94, 1985. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Mitchison and B. L. A. Carter, “Chapter 11 cell cycle analysis,” Methods in Cell Biology, vol. 11, pp. 201–219, 1975. View at Publisher · View at Google Scholar
  41. M. G. Hertog, P. C. Hollman, M. B. Katan, and D. Kromhout, “Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands,” Nutrition and Cancer, vol. 20, no. 1, pp. 21–29, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Chaumontet, M. Suschetet, E. Honikman-Leban et al., “Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication,” Nutrition and Cancer, vol. 26, no. 3, pp. 251–263, 1996. View at Publisher · View at Google Scholar
  43. S. Sharma, A. Ali, J. Ali, J. K. Sahni, and S. Baboota, “Rutin: therapeutic potential and recent advances in drug delivery,” Expert Opinion on Investigational Drugs, vol. 22, no. 8, pp. 1063–1079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Kanis and C. C. Glüer, “An update on the diagnosis and assessment of osteoporosis with densitometry,” Osteoporosis International, vol. 11, no. 3, pp. 192–202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. T. D. Rachner, S. Khosla, and L. C. Hofbauer, “Osteoporosis: now and the future,” The Lancet, vol. 377, no. 9773, pp. 1276–1287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Parisuthiman, Y. Mochida, W. R. Duarte, and M. Yamauchi, “Biglycan modulates osteoblast differentiation and matrix mineralization,” Journal of Bone and Mineral Research, vol. 20, no. 10, pp. 1878–1886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Sapir-Koren and G. Livshits, “Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption–formation cycles?” Osteoporosis International, vol. 25, no. 12, pp. 2685–2700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Dayong Guo and L. F. Bonewald, “Advancing our understanding of osteocyte cell biology,” Therapeutic Advances in Musculoskeletal Disease, vol. 1, no. 2, pp. 87–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Li, M. S. Ominsky, Q.-T. Niu et al., “Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength,” Journal of Bone and Mineral Research, vol. 23, no. 6, pp. 860–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Rassi, M. Lieberherr, G. Chaumaz, A. Pointillart, and G. Cournot, “Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin,” Cell and Tissue Research, vol. 319, no. 3, pp. 383–393, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Komori, “Roles of runx2 in skeletal development,” Advances in Experimental Medicine and Biology, vol. 962, pp. 83–93, 2017. View at Publisher · View at Google Scholar · View at Scopus
  52. H. M. Abdallah, A. M. Al-Abd, G. F. Asaad, A. B. Abdel-Naim, and A. M. El-halawany, “Isolation of antiosteoporotic compounds from seeds of Sophora japonica,” PLoS One, vol. 9, no. 6, article e98559, 2014. View at Publisher · View at Google Scholar · View at Scopus